Ovarian Carcinoma — Trials

Ovarian Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

895 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 270
Recruiting: 140
Ph III recruiting: 16
Growth YoY: +23.1%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 101–102 of 102 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01558778	Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant	withdrawn	N/A	0	Roswell Park Cancer InstituteOTHER	0	Jul 9, 2012	clinicaltrials
NCT00154986	IGFBP-3 in Ovarian Cancer Invasion	unknown	N/A	30	National Taiwan University HospitalOTHER	1	Sep 12, 2005	clinicaltrials